MOLN compared with KURA: revenue, margins and what each company keeps, and the suppliers and customers both name

MOLNMolecular Partners AG

Mkt capRevenueRevenue

KURAKura Oncology, Inc.

Mkt capRevenueRevenue

Compare

MOLNMolecular Partners AG

KURAKura Oncology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MOLN1 of 4 reports

Reportimpliedrealized× implied

Oct 29 '26—▼−4.88%—

KURA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.2%▲+1.51%×0.15

May 13 '26±40.6%▼−2.07%×0.05

= impliedMOLN realized, solidKURA realized, hatchedOne scale, both sides: full bar = 41%× = |realized| ÷ impliedSource: market data

Q1 FY26

±11.2%

▼−0.47%

×0.04

Jan 12 '26±6.4%▼−2.55%×0.39

MOLNMolecular Partners AG

3.98▲+23.79%· post 3.17

Mkt cap$129.8MRevenue—Revenue—

KURAKura Oncology, Inc.

7.25▲+6.64%· post 7.27

ClosedNov 6 '26

Mkt cap$646.7MRevenue$21MQ2 FY26Revenue$67MFY25

Compare

ClosedNov 6 '26

MOLNMolecular Partners AG

KURAKura Oncology, Inc.

3.98▲+23.79%post 3.17

Price

7.25▲+6.64%post 7.27

$129.8M

Mkt cap

$646.7M

—

Revenue

$21MQ2 FY26

—

Revenue

$67MFY25

MOLN3.98▲+23.79%vsKURA7.25▲+6.64%ClosedNov 6 '26